Send to

Choose Destination
Acta Ophthalmol Scand. 1999 Aug;77(4):471-3.

Control of cytomegalovirus retinitis after combination antiretroviral therapy.

Author information

Department of Ophthalmology, University of Vienna, Medical School, Austria.



To report on AIDS patients having combination antiretroviral therapy whose cytomegalovirus (CMV) retinitis remained inactive after discontinuation of anti-CMV maintenance therapy.


We describe the course of CMV-retinitis in 3 patients with AIDS after initiation of combination antiretroviral therapy.


After cessation of anti-CMV therapy no relapse of CMV-retinitis has been observed for up to 18 months. Two of the patients developed new CMV-retinitis in the first months after initiation of combination therapy, nevertheless after further improvement of immunological parameters retinitis remained stable without anti-CMV therapy.


The sustained immunological effects of combination therapy are possibly sufficient enough to provide protection against CMV-retinitis.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center